arrow
E

Evis Sala

Fondazione Policlinico Universitario A. Gemelli IRCCS
H指数:71
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Current status and future directions of AI in prostate cancer detection on MRI: a special report from the ESUR prostate MRI working group authors

人工智能在前列腺癌MRI检测中的现状与未来方向:ESUR前列腺MRI工作组报告作者

2026-09-180
OAAI
Comparative assessment of METastasis Reporting and Data System for Prostate Cancer versus Prostate Cancer Clinical Trials Working Group 3 Criteria in assessing treatment response in patients with metastatic castration-resistant prostate cancer

比较METastasis Reporting and Data System for Prostate Cancer与Prostate Cancer Clinical Trials Working Group 3 Criteria在评估转移性去势抵抗性前列腺癌患者治疗反应中的评估方法

2026-08-200
OAAI
AI decision support for increasing prostate biopsy efficiency: a retrospective multicentre, multiscanner study

AI决策支持以提高前列腺活检效率:一项回顾性多中心、多扫描仪研究

2026-02-200
OAAI
AI medical device post-market surveillance regulations: consensus recommendations by the European Society of Radiology

人工智能医疗器械上市后监管法规:欧洲放射学会的共识建议

2025-12-120
OAAI
Which is the best timing to assess response after chemoradiation in locally advanced cervical cancer (BRILACC)?

在局部晚期宫颈癌(BRILACC)中,化疗放疗后评估反应的最佳时机是什么?

2025-09-120
OA
Multi-task deep learning for automatic image segmentation and treatment response assessment in metastatic ovarian cancer

多任务深度学习在自动图像分割和转移性卵巢癌治疗反应评估中的应用

2025-09-010
OAAI
Brain metastases from ovarian cancer: neuroradiological profile and survival overview of neurosurgical cases

卵巢癌脑转移:神经放射学特征及神经外科病例的生存概述

2025-08-210
PRE
Updated ESUR Guidelines for Endometrial Cancer: integrating MRI with the 2023 FIGO Staging Revolution

ESUR子宫内膜癌指南更新:整合MRI与2023年FIGO分期革命

2025-06-300
PRE
Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis

头对头比较成纤维细胞活化蛋白抑制剂(FAPI)放射性药物与[18F]FDG在妇科恶性肿瘤中的研究:系统文献综述和荟萃分析

2025-04-250
OA
AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study

人工智能驱动的前列腺癌检测:一项多中心、多扫描仪验证研究

2025-02-285
OA